Rhumbline Advisers Kodiak Sciences Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 50,237 shares of KOD stock, worth $323,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,237
Previous 56,511 11.1%
Holding current value
$323,023
Previous $132,000 0.76%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$2.2 - $3.25 $13,802 - $20,390
-6,274 Reduced 11.1%
50,237 $131,000
Q2 2024

Aug 01, 2024
BUY
$2.29 - $4.48 $1,341 - $2,625
586 Added 1.05%
56,511 $132,000
Q1 2024

May 09, 2024
BUY
$3.01 - $7.45 $2,576 - $6,377
856 Added 1.55%
55,925 $294,000
Q4 2023

Feb 08, 2024
BUY
$1.4 - $3.24 $439 - $1,017
314 Added 0.57%
55,069 $167,000
Q3 2023

Nov 09, 2023
SELL
$1.8 - $7.49 $3,274 - $13,624
-1,819 Reduced 3.22%
54,755 $98,000
Q2 2023

Aug 08, 2023
BUY
$4.3 - $9.48 $8,127 - $17,917
1,890 Added 3.46%
56,574 $390,000
Q1 2023

May 11, 2023
BUY
$4.81 - $8.88 $5,425 - $10,016
1,128 Added 2.11%
54,684 $339,000
Q4 2022

Feb 14, 2023
BUY
$6.52 - $8.05 $1,760 - $2,173
270 Added 0.51%
53,556 $383,000
Q3 2022

Nov 10, 2022
BUY
$7.57 - $12.5 $13,943 - $23,025
1,842 Added 3.58%
53,286 $412,000
Q2 2022

Aug 11, 2022
BUY
$5.04 - $9.48 $78,513 - $147,679
15,578 Added 43.43%
51,444 $393,000
Q1 2022

May 12, 2022
BUY
$7.09 - $89.45 $2,807 - $35,422
396 Added 1.12%
35,866 $277,000
Q4 2021

Feb 10, 2022
SELL
$80.85 - $128.49 $34,765 - $55,250
-430 Reduced 1.2%
35,470 $3.01 Million
Q3 2021

Nov 12, 2021
BUY
$81.97 - $106.94 $72,297 - $94,321
882 Added 2.52%
35,900 $3.45 Million
Q2 2021

Aug 05, 2021
SELL
$77.2 - $126.54 $161,888 - $265,354
-2,097 Reduced 5.65%
35,018 $3.26 Million
Q1 2021

May 06, 2021
SELL
$110.45 - $164.47 $297,662 - $443,246
-2,695 Reduced 6.77%
37,115 $4.21 Million
Q4 2020

Feb 10, 2021
BUY
$60.78 - $154.03 $211,210 - $535,254
3,475 Added 9.56%
39,810 $5.85 Million
Q3 2020

Nov 12, 2020
SELL
$45.05 - $59.27 $332,649 - $437,649
-7,384 Reduced 16.89%
36,335 $2.15 Million
Q2 2020

Aug 13, 2020
BUY
$42.74 - $66.25 $318,583 - $493,827
7,454 Added 20.55%
43,719 $2.37 Million
Q1 2020

May 06, 2020
BUY
$38.18 - $73.95 $258,745 - $501,159
6,777 Added 22.98%
36,265 $1.73 Million
Q4 2019

Feb 05, 2020
BUY
$13.9 - $76.65 $82,635 - $455,684
5,945 Added 25.25%
29,488 $2.12 Million
Q3 2019

Oct 23, 2019
BUY
$10.24 - $17.57 $8,867 - $15,215
866 Added 3.82%
23,543 $339,000
Q2 2019

Aug 14, 2019
BUY
$6.2 - $12.0 $140,597 - $272,124
22,677 New
22,677 $265,000

Others Institutions Holding KOD

# of Institutions
98
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $335M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email